Important note: Information in this article was accurate in November 2006. The state of the art may have changed since the publication date.
HIV Treatment Bulletin - Vol. 7, No. 11/12, November/December 2006
Indian generic manufacturer Emcure Ltd has announced the production and availability of a heat-stable formulation of ritonavir called Empetus.
Emcure has produced other genetic ARVs, including atazanavir under voluntary license from BMS, which has recently been introduced.
Empetus is available in bottles of 30 tablets costing about $20 per month and still requires WHO pre-qualification.
This generic formulation has been produced prior to a heat stable version of ritonavir from Abbott.
2006-11-10
IB060711-20
©2006. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.